Scholarlink

Background <p>Erectile dysfunction (ED), a prevalent male sexual disorder, severely impacts quality of life. Extracellular vesicles (EVs), natural nanoparticles (30–200&#xa0;nm) secreted by stem cells, represent a novel nanomedicine platform for ED treatment due to their ability to encapsulate bioactive cargo (e.g., miRNAs, proteins) and target damaged tissues. Stem cell-derived extracellular vesicles (SC-EVs) have emerged as a promising therapeutic strategy for multiple diseases. This meta-analysis evaluates the therapeutic efficacy of SC-EVs in rat ED models and explores their translational potential.</p> Methods <p>We systematically searched PubMed, Embase, Cochrane Library, and Web of Science for studies published up to December 2024. Randomized controlled trials (RCTs) assessing EVs in ED treatment were included. A random-effects model was applied to account for between-study heterogeneity, with standardized mean differences (SMDs) and 95% confidence intervals (CIs) calculated for continuous outcomes.</p> Results <p>Twenty studies involving 324 rats were included. EVs significantly improved erectile function (SMD = 4.19, 95% CI: 3.31–5.08,&#xa0;<i>P</i> &lt; 0.00001). Subgroup analyses revealed no significant differences between EV sources (e.g., mesenchymal stem cells [MSCs] vs. adipose-derived stem cells [ADSCs],&#xa0;<i>P</i> &gt; 0.05) or disease models (diabetes mellitus [DM] vs. cavernous nerve injury [CNI],&#xa0;<i>P</i> &gt; 0.05). EVs upregulated the expression of nitric oxide synthase isoforms (nNOS and eNOS), increased smooth muscle content (α-SMA), and improved smooth muscle-to-collagen ratios (<i>P</i> &lt; 0.00001 for all). Funnel plot asymmetry and Egger’s test (<i>P</i> &lt; 0.05) indicated publication bias, but trim-and-fill analysis confirmed robust results post-adjustment.</p> Conclusion <p>SC-EVs demonstrate significant therapeutic potential for ED in rat models, particularly in restoring vascular and neural integrity. However, limitations include small sample sizes and short follow-up periods. Future research should prioritize clinical translation, mechanistic exploration, and standardized EV production protocols.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nanoscale therapeutics for erectile dysfunction: a meta-analysis of stem cell-derived extracellular vesicles as natural nanoparticles in diabetic rat models

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月2日

查看全文
  • Kecheng Lou,
  • Junjie Hu,
  • Jiayue Tong,
  • Zhanshi Wang

摘要

Background

Erectile dysfunction (ED), a prevalent male sexual disorder, severely impacts quality of life. Extracellular vesicles (EVs), natural nanoparticles (30–200 nm) secreted by stem cells, represent a novel nanomedicine platform for ED treatment due to their ability to encapsulate bioactive cargo (e.g., miRNAs, proteins) and target damaged tissues. Stem cell-derived extracellular vesicles (SC-EVs) have emerged as a promising therapeutic strategy for multiple diseases. This meta-analysis evaluates the therapeutic efficacy of SC-EVs in rat ED models and explores their translational potential.

Methods

We systematically searched PubMed, Embase, Cochrane Library, and Web of Science for studies published up to December 2024. Randomized controlled trials (RCTs) assessing EVs in ED treatment were included. A random-effects model was applied to account for between-study heterogeneity, with standardized mean differences (SMDs) and 95% confidence intervals (CIs) calculated for continuous outcomes.

Results

Twenty studies involving 324 rats were included. EVs significantly improved erectile function (SMD = 4.19, 95% CI: 3.31–5.08, P < 0.00001). Subgroup analyses revealed no significant differences between EV sources (e.g., mesenchymal stem cells [MSCs] vs. adipose-derived stem cells [ADSCs], P > 0.05) or disease models (diabetes mellitus [DM] vs. cavernous nerve injury [CNI], P > 0.05). EVs upregulated the expression of nitric oxide synthase isoforms (nNOS and eNOS), increased smooth muscle content (α-SMA), and improved smooth muscle-to-collagen ratios (P < 0.00001 for all). Funnel plot asymmetry and Egger’s test (P < 0.05) indicated publication bias, but trim-and-fill analysis confirmed robust results post-adjustment.

Conclusion

SC-EVs demonstrate significant therapeutic potential for ED in rat models, particularly in restoring vascular and neural integrity. However, limitations include small sample sizes and short follow-up periods. Future research should prioritize clinical translation, mechanistic exploration, and standardized EV production protocols.